Meta-Analysis of Epidermal Growth Factor Polymorphisms and Cancer Risk: Involving 9,779 Cases and 15,932 Controls
- 1 April 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in DNA and Cell Biology
- Vol. 31 (4), 568-574
- https://doi.org/10.1089/dna.2011.1394
Abstract
The epidermal growth factor (EGF) pathway stimulates proliferation and differentiation of epidermal and epithelial tissues, and plays an important role in tumorigenesis. The association between EGF polymorphisms and cancer risk is controversial; thus, we performed this meta-analysis. Overall, 41 case–control studies with 9,779 cases and 15,932 controls were retrieved. We found that EGF +61A/G polymorphism increased overall cancer risk (G allele vs. A allele: OR=1.181, 95% CI=1.077–1.295, Pheterogeneity < 0.001; GG vs. AA: OR=1.370, 95% CI=1.143–1.641, Pheterogeneity < 0.001; GG+GA vs. AA: OR=1.175, 95% CI=1.047–1.318, Pheterogeneity < 0.001). In the stratified analysis by cancer type, the +61 G allele was a risk factor for colorectal cancer, esophageal carcinoma, gastric cancer, and hepatocellular carcinoma. Individuals who carried +61G allele had higher cancer susceptibility in mixed and European racial subgroups. An increased association was detected in the hospital-based subgroup. No significant association was found among EGF −1380A/G, −1744G/A, rs6983267T/G polymorphisms and cancer risk.Keywords
This publication has 51 references indexed in Scilit:
- A Functional Polymorphism in the Epidermal Growth Factor Gene Is Associated With Risk for Hepatocellular CarcinomaGastroenterology, 2011
- Association between EGF +61 G/A and glioma risk in a Chinese populationBMC Cancer, 2010
- Role of the EGF +61A>G polymorphism in melanoma pathogenesis: an experience on a large series of Italian cases and controlsBMC Dermatology, 2009
- Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma riskCarcinogenesis: Integrative Cancer Research, 2009
- Genetic Susceptibility to CancerJAMA, 2008
- A Functional Epidermal Growth Factor (EGF) Polymorphism, EGF Serum Levels, and Esophageal Adenocarcinoma Risk and OutcomeClinical Cancer Research, 2008
- Mechanisms of hepatocyte growth factor-mediated and epidermal growth factor-mediated signaling in transdifferentiation of rat hepatocytes to biliary epitheliumHepatology, 2008
- Biology of Interactions: Antiepidermal Growth Factor Receptor AgentsJournal of Clinical Oncology, 2007
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986